Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD52 | P43351 | 1/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | GNAI3 | P08754 | 5/20 | 0.46 |
| ▸ | GNAO1 | P09471 | 5/20 | 0.46 |
| ▸ | GNAI1 | P63096 | 5/20 | 0.46 |
| ▸ | VCP | P55072 | 2/20 | 0.43 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.38 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22123351 | 0.94 | RAD52 (0.82) | RAD52HSD17B10GNAI3GNAO1GNAI1 | |
| SCHEMBL28637244 | 0.90 | RAD52 (0.96) | RAD52HSD17B10GNAI3GNAO1GNAI1 | |
| SCHEMBL14302740 | 0.85 | RAD52 (0.70) | RAD52HSD17B10GNAI3GNAO1GNAI1 | |
| SCHEMBL12120528 | 0.79 | RAD52 (0.57) | RAD52HSD17B10GNAI3GNAO1GNAI1 | |
| Bromide SCHEMBL1307130 | 0.78 | RAD52 (0.56) | RAD52HSD17B10GNAI3GNAO1GNAI1 | |
| SCHEMBL20124124 | 0.78 | RAD52 (0.81) | RAD52HSD17B10GNAI3GNAO1GNAI1 | |
| SCHEMBL17484488 | 0.78 | RAD52 (0.60) | RAD52GNAI3GNAO1GNAI1SOS1 | |
| SCHEMBL24352354 | 0.78 | RAD52 (0.59) | RAD52HSD17B10GNAI3GNAO1GNAI1 | |
| SCHEMBL22943277 | 0.76 | GNAI3 (0.53) | RAD52GNAI3GNAO1GNAI1SOS1 | |
| SCHEMBL17484491 | 0.75 | RAD52 (0.49) | RAD52GNAI3GNAO1GNAI1VCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160031893-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | BioVersys AG (CH) | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160031893-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | MPO, LPO, CAT | RAD52 1404/4885HSD17B10 1504/4885GNAI3 3587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.